CURE’s skin cancer page is an extensive resource of cancer information featuring the latest skin cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on skin cancer.
June 27th 2019
In this week’s episode of “CURE Talks Cancer,” we spoke with a melanoma survivor who wishes she knew at diagnosis what her cancer journey would do for her – not to her.
June 11th 2019
A nine-year breast cancer survivor and five-year melanoma survivor shares her thoughts on cancer survivorship with a side of mid-life crisis.
June 5th 2019
In a talk to people affected by melanoma, Michael McGrady described reassessing his values after cancer and how it changed the course of his life.
May 29th 2019
Following surgery with medication, combining immunotherapies or targeted drugs and adding radiation to immunotherapy can improve effectiveness in treating various stages of melanoma.
May 24th 2019
With greater longevity for survivors of melanoma comes the need to treat lingering side effects and monitor for cancer recurrences.
May 16th 2019
Immunotherapy may be giving hope to people living with rare skin cancer.
February 19th 2019
The Food and Drug Administration (FDA) approved Keytruda (pembrolizumab) – an immunotherapy agent – for the treatment of patients with resected, high-risk, stage 3 melanoma.
February 7th 2019
Here are tips for fellow cancer survivors to clear out cancer paraphernailia but keep important medical records.
January 14th 2019
Two-time cancer survivor suggests a careful approach when researching your own cancer.
December 27th 2018
A web-based intervention may help reduce harmful UV exposure and skin cancer risk in young adults, according to recent research.
December 20th 2018
The Food and Drug Administration (FDA) granted accelerated approval to Keytruda (pembrolizumab) for the treatment of adult and pediatric patients with recurrent locally advanced or metastatic Merkel cell carcinoma, according to the agency.
November 16th 2018
Young patients diagnosed with posterior uveal melanoma may have similar, if not worse, prognoses compared with the overall patient population.
November 15th 2018
Patients with BRAF wild-type advanced melanoma saw a survival benefit after treatment with Opdivo (nivolumab) compared with the chemotherapy agent dacarbazine.
November 15th 2018
The combination use of two immunotherapy agents in the first-line setting helped patients with advanced melanoma live longer compared with treatment with either drug alone.
October 22nd 2018
To combat the psychological effects from a lymphedema diagnosis, patients need to be equipped with the knowledge and understanding of what the condition is and how it is treated.
October 20th 2018
A genetic counselor discussed the various hereditary breast and ovarian cancer syndrome-associated cancers among men and how to manage them at the FORCE Annual Meeting.
October 17th 2018
As part of the Bristol-Myers Squibb Coast 2 Coast 4 Cancer Research ride, 109 company employees rode from Oregon to New Jersey to help raise funds for the V Foundation for Cancer Research.
October 15th 2018
The panelists acknowledged that many individuals face barriers to receiving regular skin check-ups. Some people – especially those in rural areas – may not have a dermatologist near them. And even if they do make it in to a doctor’s office for a skin check-up, they may not be checked as thoroughly as they should be.
October 13th 2018
Lynn Schuchter, M.D., discussed immunotherapy and BRAF/MEK inhibition at the Melanoma Action Coalition’s Fall Conference.
September 16th 2018
Substitute thinking "life management" instead of "time management."
September 11th 2018
Two-time cancer survivor encourages fellow survivors to develop resilience to cope with cancer.
September 7th 2018
I felt like cancer had forced me to do other "uncomfortable" things instead of the bucket list I had chosen.
September 4th 2018
The Food and Drug Administration (FDA) granted priority review to a new supplemental biologics license application for Keytruda (pembrolizumab) to treat adult and pediatric patients with recurrent locally advanced or metastatic Merkel cell carcinoma, according to Merck, the agent’s manufacturer.
August 16th 2018
Researchers noted that melanoma diagnosis and treatment did not cause many women to put off becoming pregnant.
August 15th 2018
Individuals diagnosed with a high frequency of basal cell carcinomas, a common type of skin cancer, may be at an increased for developing an unrelated cancer, highlighting the need for additional clinical screening.
August 7th 2018
Patients who receive anti-PD-1 therapies may experience delayed cutaneous side effects like lesions, eczema or psoriasis, even after treatment has ended.
July 30th 2018
Clinical trials seek to discover new ways to attack the disease, limit metastasis and prevent recurrence.
July 28th 2018
Creating a medical family tree is helpful. If cancer is common, noting which branches include it can help inform decisions.